BlackRock Investment Management, LLC - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 90 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q4 2016$596,000
+3.1%
147,819
-2.0%
0.00%0.0%
Q3 2016$578,000
-11.1%
150,906
-0.1%
0.00%0.0%
Q2 2016$650,000
+13.8%
151,120
+22.5%
0.00%0.0%
Q1 2016$571,000
-52.9%
123,353
+2.0%
0.00%
-50.0%
Q4 2015$1,213,000
+35.4%
120,917
+0.7%
0.00%
+100.0%
Q3 2015$896,000
-87.5%
120,115
-20.3%
0.00%
-88.9%
Q2 2015$7,150,000
+84.9%
150,725
+42.8%
0.01%
+80.0%
Q1 2015$3,868,000
+30.4%
105,568
+41.4%
0.01%
+25.0%
Q4 2014$2,966,000
+132.4%
74,681
+16.7%
0.00%
+100.0%
Q3 2014$1,276,000
+49.4%
63,984
+1.1%
0.00%
+100.0%
Q2 2014$854,000
+100.9%
63,302
+62.3%
0.00%0.0%
Q1 2014$425,000
-17.2%
38,997
+2.8%
0.00%0.0%
Q4 2013$513,000
+39.4%
37,919
+17.2%
0.00%0.0%
Q3 2013$368,000
+84.0%
32,367
+13.9%
0.00%
Q2 2013$200,00028,4280.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q1 2017
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 293,675$14,061,0004.76%
BB BIOTECH AG 1,507,114$71,497,0001.94%
SECTORAL ASSET MANAGEMENT INC 893,076$42,368,0001.77%
Opaleye Management Inc. 65,000$3,084,0001.23%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 390,294$18,515,0001.14%
Granite Point Capital Management, L.P. 75,206$3,568,0001.04%
Granahan Investment Management 705,601$33,474,0000.95%
Iguana Healthcare Management, LLC 50,000$2,372,0000.75%
Eventide Asset Management 290,000$13,758,0000.74%
Rhenman & Partners Asset Management AB 107,400$5,095,0000.61%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders